Ubs Oconnor LLC Amgen Inc Transaction History
Ubs Oconnor LLC
- $1.46 Billion
- Q3 2024
A detailed history of Ubs Oconnor LLC transactions in Amgen Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 10,000 shares of AMGN stock, worth $2.98 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$2.98 Million% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMGN
# of Institutions
3,087Shares Held
402MCall Options Held
7.57MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.6 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.73 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.38 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.25 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $159B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...